Potential Lawsuit: Proton Pump Inhibitors Linked with Higher Rates of Gastric Cancer in H Pylori Patients

Santa Cruz, CA: A new study on the use of proton pump inhibitors (PPI) in patients who have been treated successfully for Helicobacter pylori shows that the drugs more than double the risk for gastric cancer.